Identification of fungal candidates for asthma protection in a large population-based study

Susanne Mueller-Rompa1, Tobias Janke2, Karin Schwaiger2

  • 1Dr von Hauner Children's Hospital, Ludwig Maximilians University Munich, Munich, Germany.

Abstract

Insights

Certain fungi in dust may protect children from asthma. This study identified specific fungal DNA in mattress dust linked to reduced asthma risk, offering new avenues for asthma prevention research.

Area of Science:

  • Environmental microbiology
  • Immunology
  • Molecular biology

Background:

  • Mold exposure is linked to asthma, with complex effects.
  • Current methods struggle to identify all relevant fungi, especially non-culturable ones.
  • Understanding fungal roles in asthma requires advanced molecular techniques.

Purpose of the Study:

  • To identify fungal candidates in environmental dust associated with protection against childhood asthma.
  • To utilize comprehensive molecular methods for detecting cultivable, non-cultivable, and non-viable fungi.
  • To explore the immunoregulatory potential of fungi in asthma.

Main Methods:

  • Analysis of mattress dust samples from 844 children using Polymerase Chain Reaction-Single-Strand Conformation Polymorphism (PCR-SSCP).
  • Targeted analysis of known asthma-associated fungal species within the Internal Transcribed Spacer (ITS) region.
  • Data-driven approach to identify novel fungal associations with asthma risk by examining individual gel positions.

Main Results:

  • Penicillium chrysogenum DNA was associated with a reduced risk of asthma (OR=0.80).
  • Fungal DNA from Metschnikowia, Aureobasidium, Epicoccum, Galactomyces, and uncultured Penicillium also showed protective associations.
  • DNA of Pseudotaeniolina globosa was identified as a novel protective factor against asthma (OR=0.80).

Conclusions:

  • Several fungal taxa in dust are inversely associated with childhood asthma.
  • Fungi produce bioactive compounds with potential immunoregulatory effects relevant to asthma.
  • These findings highlight fungi as promising targets for future asthma research and potential therapeutic strategies.

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
2.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.2K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K